5Am Ventures Iv, L.P. has bought stock on 3 days since Jul 2018
10% owner at Leverage Shares 2X Long FIX Daily ETF, and 3 other companies
SEC CIK 0001589315 · Filings on SEC.gov ↗
5Am Ventures Iv, L.P.'s record
3 months after each buy, from the first price a copier could get.
No buys have 3 months of prices yet. A record shows here at 3.
Companies
Every filing
17 filings since Jul 2018, newest first
Homology Medicines, Inc.
10% owner
Homology Medicines, Inc.
10% owner
Ideaya Biosciences, Inc.
10% owner
Aprea Therapeutics, Inc.
Former 10% holder
Aprea Therapeutics, Inc.
10% owner
Aprea Therapeutics, Inc.
10% owner
Aprea Therapeutics, Inc.
10% owner
Aprea Therapeutics, Inc.
10% owner
Crinetics Pharmaceuticals, Inc.
Former 10% holder
Ideaya Biosciences, Inc.
10% owner
Homology Medicines, Inc.
10% owner
Crinetics Pharmaceuticals, Inc.
10% owner
Crinetics Pharmaceuticals, Inc.
10% owner
Homology Medicines, Inc.
10% owner
Homology Medicines, Inc.
10% owner
Homology Medicines, Inc.
10% owner
Crinetics Pharmaceuticals, Inc.
10% owner
About 5Am Ventures Iv, L.P.
5Am Ventures IV, L.P. is a company—a life science venture capital fund managed by 5AM Venture Management, LLC. 5AM Ventures was founded in 2002 and focuses on investing in next-generation life science and biopharmaceutical companies, including company creation, growth-stage private investments, and public biopharma opportunities.(
5AM Ventures IV, L.P. was announced as a $250 million venture capital fund focused on building life science companies.( The broader 5AM platform has raised multiple funds over time, and the firm is led by managing partners Andrew Schwab and Kush Parmar.( 5AM’s headquarters are in San Francisco, California, with an additional Boston location, and its strategy emphasizes advanced life science innovations across therapeutics and platform technologies.(
Written by Perplexity from public sources.
Filings come from SEC EDGAR. Not investment advice.